In April, Mayo Clinic announced the launch of a cancer gene panel performed by next generation sequencing.
This cancer tumor gene panel is a test that can be used for patients who have solid tumors such as lung, colon, breast, kidney and liver cancers.
The gene panel looks at the patient’s tumor cells and tests for 50 genes that can affect tumor growth and could identify specific treatment options directed against the genetic mutation.
Read more here
The test is now available to Mayo Clinic patients and to oncologists worldwide through Mayo Medical Laboratories.
For more information, see http://newsnetwork.mayoclinic.org/discussion/mayo-clinic-launches-50-gene-cancer-panel-test.
Patients can be evaluated through The Mayo Clinic Center for Individualized Medicine, which is home to the Individualized Medicine Clinic, the world’s first integrated multidisciplinary genomics clinic, serving patients with advanced cancer and complex diagnoses.
The center discovers and integrates the latest in genomic, molecular and clinical sciences into personalized care for each Mayo Clinic patient. For more, visit: http://mayoresearch.mayo.edu/center-for-individualized-medicine.
The Gene Panel Test at Mayo is specifically looking at a collection of the 50 known cancer genes – check out this link for more information from Dr. Axel Grothey – http://newsnetwork.mayoclinic.org/discussion/mayo-clinic-launches-50-gene-cancer-panel-test